Fol. Biol. 2003, 49, 95-99
https://doi.org/10.14712/fb2003049030095
Prospects for Immunotherapy of MHC Class I-Deficient Tumours
Individual author index pages
Other articles of these authors
-
Interleukin 12 in Cancer Treatment
Jan Bubeník
2011, Vol. 57, Issue 1, pp. 1-2 -
Gene Therapy of Cancer by Vaccines Carrying Inserted Immunostimulatory Genes
Jan Bubeník
2007, Vol. 53, Issue 3, pp. 71-73 -
Depletion of Treg Cells Augments the Therapeutic Effect of Cancer Vaccines
Jan Bubeník
2006, Vol. 52, Issue 6, pp. 202-204 -
Human Papillomavirus (HPV) and HPV-Associated Tumour Vaccines
Jan Bubeník
2006, Vol. 52, Issue 1-2, pp. 45-46 -
MHC Class I Downregulation, Tumour Escape from Immune Surveillance and Design of Therapeutic Strategies
Jan Bubeník
2005, Vol. 51, Issue 1, pp. 1-2 -
Dedication to Professor Jan Svoboda, Ph.D., D.Sc.
Jan Bubeník
2004, Vol. 50, Issue 3-4, pp. 77-77 -
Interleukin-2 Therapy of Cancer
Jan Bubeník
2004, Vol. 50, Issue 3-4, pp. 120-130
